Last week, California’s Institute for Regenerative Medicine (CIRM) announced a $15.9 million grant awarded to Israeli-based Brainstorm Cell Therapeutics. The grant will support a Phase III study for a stem cell based treatment of Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. The Israel Economic Mission to the West Coast was instrumental in creating … [Read more...]